Red Flags in Compounded GLP-1 Sellers

By Alsen Walker · Editorially reviewed on 25 August 2026 · Not medically reviewed by a clinician

The reliable warning signs are structural rather than clinical, which means you can apply them without any pharmacology. If a seller will not name the pharmacy, will not identify the prescriber, sells without a prescription, or tells you a compounded product is FDA-approved, you have enough information to stop.

For the wider picture on compounded products and how to check a supplier, see Compounded GLP-1s: What They Are and How to Check a Supplier.

Red flags in what they sell

Sold without a prescription. These are prescription medications. Anywhere selling without one is operating outside the system entirely.

Described as FDA-approved. No compounded GLP-1 is FDA-approved. A seller stating otherwise is either misinformed about their own product or lying.

Labelled research use only or not for human consumption. That labelling exists to evade drug regulation. It is not a formality.

Sold as semaglutide sodium or acetate without clearly explaining these are not the active ingredient in approved products.

Combination products mixing in other substances, where the rationale is marketing rather than clinical.

Red flags in how they sell

No named, contactable prescriber. If nobody is clinically responsible, nobody is clinically responsible when something goes wrong.

A consultation that is a form. A questionnaire nobody reviews is not a clinical assessment, whatever it is called.

No questions about your history. A legitimate prescriber asks about thyroid cancer history, pancreatitis, pregnancy plans and your other medications. A seller that asks none of these is not assessing you.

Pressure tactics. Countdown timers, bulk discounts, subscriptions that are hard to cancel. Medicine is not sold this way.

Payment by cryptocurrency or bank transfer only. Methods chosen for irreversibility.

Influencer and affiliate promotion as the main channel, particularly with discount codes and undisclosed commercial relationships.

Red flags in what arrives

No pharmacy label with your name, the drug, the concentration and the pharmacy details.

Dosing instructions in insulin units with no clear milligram conversion.

Packaging that differs from what you received before, or from what was described.

Product appearance inconsistent with the description, though appearance alone proves little in either direction.

Shipping without cold chain protection where refrigeration is required.

What is not a reliable signal

A professional website. Presentation is cheap.

Testimonials and before-and-after photographs, which can be bought.

A US address, which does not establish that the product or the pharmacy is legitimate.

Price alone. Cheap is a flag; expensive is not reassurance.

If you have already used one

Tell a prescriber what you took, including the source and the concentration if you know it.

Report problems to FDA MedWatch and to your state board of pharmacy. Individual reports are what trigger investigations.

Do not simply continue because nothing has gone wrong yet.

Frequently asked questions

What is the quickest check?
Ask which pharmacy prepares it, by name, and verify that pharmacy with the state board.

Is a doctor consultation enough reassurance?
Only if there is a named prescriber licensed in your state whom you can contact.

Are cheaper products always suspect?
Unusually cheap is a flag. Expensive is not evidence of anything.

What if it worked fine last time?
Batch consistency is exactly what unapproved products do not guarantee.

Can I test it myself?
Not meaningfully. This is why supply chain matters more than inspection.

Where do I report a seller?
FDA MedWatch, your state board of pharmacy, and your state attorney general for consumer issues.